We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

3 hedge funds and large institutions have $50 invested in LakeShore Biopharma Warrants in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more capital invested

Capital invested by funds: $32 → $50 (+$18)

0% more funds holding

Funds holding: 3 → 3 (0)

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HIM
1
HGC Investment Management
Ontario, Canada
$35 – – –
AA
2
Ancora Advisors
Ohio
$15 – – –

LSBPW Hedge Fund Activity: Q4 2025 in Review

3 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q4 2025, worth a combined $50 — up 56% from $32 a quarter earlier.

Fund positioning in LSBPW was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 3 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $50 of LakeShore Biopharma Warrants stock for Q4 2025, up 56% quarter-over-quarter.
  • 0 funds opened new LakeShore Biopharma Warrants positions in Q4 2025 and 0 closed out.

Based on aggregated 13F filings for Q4 2025.